Effect of estrogen/progestin potency on lipid/lipoprotein cholesterol.
暂无分享,去创建一个
P. Wahl | R. Wallace | G. Heiss | B. Rifkind | R. Knopp | C. Walden | J. Hoover | B. Rifkind | Robert B. Wallace | Gerardo Heiss
[1] P. Wahl,et al. Oral contraceptive and postmenopausal estrogen effects on lipoprotein triglyceride and cholesterol in an adult female population: relationships to estrogen and progestin potency. , 1981, The Journal of clinical endocrinology and metabolism.
[2] B. Stadel. Oral contraceptives and cardiovascular disease (first of two parts). , 1981, The New England journal of medicine.
[3] S. Shapiro,et al. Risk of myocardial infarction in relation to current and discontinued use of oral contraceptives. , 1981, The New England journal of medicine.
[4] W. Willett,et al. Use of Postmenopausal Hormones and Risk of Myocardial Infarction , 1981, Circulation.
[5] V. Manninen,et al. Effects of Different Progestogens on Lipoproteins during Postmenopausal Replacement Therapy , 1981 .
[6] P. Wilson,et al. Prevalence of coronary heart disease in the Framingham Offspring Study: role of lipoprotein cholesterols. , 1980, The American journal of cardiology.
[7] S. Thompson,et al. Progestogens and cardiovascular reactions associated with oral contraceptives and a comparison of the safety of 50- and 30-microgram oestrogen preparations. , 1980, British medical journal.
[8] D. Jacobs,et al. Lipoprotein‐Cholesterol Distributions in Selected North American Populations: The Lipid Research Clinics Program Prevalence Study , 1980, Circulation.
[9] B. Rosner,et al. Oral Contraceptive Use and Fasting Triglyceride, Plasma Cholesterol and HDL Cholesterol , 1979, Circulation.
[10] L. Wilkins. Plasma Lipid Distributions in Selected North American Populations: The Lipid Research Clinics Program Prevalence Study THE LIPID RESEARCH CLINICS PROGRAM EPIDEMIOLOGY COMMITTEE , 1979, Circulation.
[11] E. Barrett-Connor,et al. ALTERED PLASMA LIPID AND LIPOPROTEIN LEVELS ASSOCIATED WITH ORAL CONTRACEPTIVE AND ŒSTROGEN USE Report from the Medications Working Group of the Lipid Research Clinics Program , 1979, The Lancet.
[12] I. Godsland,et al. COMPARISON OF EFFECTS OF DIFFERENT COMBINED ORAL-CONTRACEPTIVE FORMULATIONS ON CARBOHYDRATE AND LIPID METABOLISM , 1979, The Lancet.
[13] L. Wallentin,et al. EFFECTS OF THREE DIFFERENT COMBINATIONS OF ETHINYL ESTRADIOL AND LEVONORGESTREL ON PLASMA LIPIDS AND HIGH DENSITY LIPOPROTEINS , 1979, Acta obstetricia et gynecologica Scandinavica. Supplement.
[14] D. Kleinbaum,et al. Applied Regression Analysis and Other Multivariate Methods , 1978 .
[15] R. Krauss,et al. Serum high-density-lipoprotein cholesterol in women using oral contraceptives, estrogens and progestins. , 1978, The New England journal of medicine.
[16] R. Krauss,et al. Changes in serum high density lipoproteins in women on oral contraceptive drugs. , 1977, Clinica chimica acta; international journal of clinical chemistry.
[17] R. Wallace,et al. ALTERED PLASMA-LIPIDS ASSOCIATED WITH ORAL CONTRACEPTIVE OR ŒSTROGEN CONSUMPTION The Lipid Research Clinic Program , 1977, The Lancet.
[18] P. Steiner,et al. Plasma high-density lipoprotein cholesterol concentrations determined after removal of other lipoproteins by heparin/manganese precipitation or by ultracentrifugation. , 1976, Clinical chemistry.
[19] M. Thorogood,et al. Oral contraceptive use in older women and fatal myocardial infarction. , 1976, British medical journal.
[20] R. Edgren,et al. Potencies of oral contraceptives. , 1976, American journal of obstetrics and gynecology.
[21] Dickey Rp,et al. Progestational potency of oral contraceptives. , 1976 .
[22] C. Glueck,et al. Effects of estrogenic compounds on triglyceride kinetics. , 1975, Metabolism: clinical and experimental.
[23] U. Donde,et al. The effect of combination and low dose progestogen oral contraceptives on serum lipids. , 1975, Fertility and sterility.
[24] R. Dickey,et al. Estrogen potency of oral contraceptive pills. , 1975, American journal of obstetrics and gynecology.
[25] D. Mishell. Current status of contraceptive steroids and the intrauterine device. , 1974, Clinical obstetrics and gynecology.
[26] F. Davidoff,et al. Marked hyperlipidemia and pancreatitis associated with oral contraceptive therapy. , 1973, The New England journal of medicine.
[27] A. Svanborg,et al. Gonadal steroid effects on plasma lipoproteins and individual phospholipids. , 1972, The Journal of clinical endocrinology and metabolism.
[28] V. Wynn,et al. Fasting serum triglyceride, cholesterol, and lipoprotein levels during oral-contraceptive therapy. , 1969, Lancet.
[29] W. Hazzard,et al. Studies on the mechanism of increased plasma triglyceride levels induced by oral contraceptives. , 1969, The New England journal of medicine.
[30] H. Barber,et al. Are the pills safe , 1969 .
[31] O. J. Dunn. Multiple Comparisons Using Rank Sums , 1964 .